{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:51:01Z","timestamp":1762865461624},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s12094-008-0267-9","type":"journal-article","created":{"date-parts":[[2008,10,31]],"date-time":"2008-10-31T07:05:29Z","timestamp":1225436729000},"page":"660-664","source":"Crossref","is-referenced-by-count":2,"title":["Risk-reduction surgery in BRCA mutation carriers in a Spanish population: adherence and results"],"prefix":"10.1007","volume":"10","author":[{"given":"Pedro","family":"P\u00e9rez Segura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Olivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel Andr\u00e9s","family":"Conejero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trinidad","family":"Cald\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"de la Hoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Mar\u00eda","family":"Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arancha","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Puente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"D\u00edaz-Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,1]]},"reference":[{"key":"267_CR1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y. Mik","year":"1994","unstructured":"Mik Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66\u201371","journal-title":"Science"},{"key":"267_CR2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R. Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Swift S et al (1995) Identification of BRCA2 gene. Nature 378:789\u2013792","journal-title":"Nature"},{"key":"267_CR3","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B. Fisher","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL et al (1998) Tamoxifen for prevention of breast cancer: report of the NSABP P-1 study. J Natl Cancer Inst 90:1371\u20131388","journal-title":"J Natl Cancer Inst"},{"key":"267_CR4","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","volume":"97","author":"B. Fisher","year":"2005","unstructured":"Fisher B, Costantino JP, Wickerham DL et al (2005) Tamoxifen for prevention of breast cancer: current status of the NSABP P-1 study. J Natl Can cer Inst 97:1652\u20131662","journal-title":"J Natl Can cer Inst"},{"key":"267_CR5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(98)85012-5","volume":"352","author":"T. Powles","year":"1998","unstructured":"Powles T, Eeles R, Ashley S et al (1998) Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital. Tamoxifen randomised chemoprevention trial. Lancet 352:98\u2013101","journal-title":"Lancet"},{"key":"267_CR6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(98)85011-3","volume":"352","author":"U. Veronesi","year":"1998","unstructured":"Veronesi U, Maisonneuve P, Costa A et al (1998) Prevention of breast cancer with tamoxifen: preliminary findings from the Italian Tamoxifen Prevention Study. Lancet 352:93\u201397","journal-title":"Lancet"},{"key":"267_CR7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(03)12342-2","volume":"361","author":"T. Cuzick","year":"2003","unstructured":"Cuzick T, Powles T, Veronesi U et al (2003) Overview of the main outcomes in breast cancer prevention trials. Lancet 361:296\u2013300","journal-title":"Lancet"},{"key":"267_CR8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1006478317173","volume":"65","author":"J.A. Cauley","year":"2001","unstructured":"Cauley JA, Norton L, Lippmann ME et al (2001) Continued breast cancer risk reduction in postmenopausal women treated with raloxifen: 4-year results from the MORE trial. Multiple outcomes of raloxifen evaluation. Breast Cancer Res Treat 65:125\u2013134","journal-title":"Breast Cancer Res Treat"},{"key":"267_CR9","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","volume":"286","author":"M.C. King","year":"2001","unstructured":"King MC, Wieand S, Hale K et al (2001) Tamoxifen and breast cancer incidence among women with inherited mutations of BRCA1 and BRCA2. JAMA 286:2251\u20132256","journal-title":"JAMA"},{"key":"267_CR10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ijc.20429","volume":"112","author":"R. Calderon-Margalit","year":"2004","unstructured":"Calderon-Margalit R, Paltiel O (2004) Prevention of breast cancer in women who carry BRCA1 and BRCA2 mutation: a critical review of the literature. Int J Cancer 112:357\u2013364","journal-title":"Int J Cancer"},{"key":"267_CR11","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(00)03258-X","volume":"356","author":"S.Y. Narod","year":"2000","unstructured":"Narod SY, Brunet JS, Ghadinan P et al (2000) Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet 356:1876\u20131881","journal-title":"Lancet"},{"key":"267_CR12","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1200\/JCO.2005.02.7045","volume":"23","author":"S. Bonovas","year":"2005","unstructured":"Bonovas S, Filioussi K, Tsavaris N, Sitaras NM et al (2005) Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies. J Clin Oncol 23:8606\u20138612","journal-title":"J Clin Oncol"},{"key":"267_CR13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"T.R. Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T, Lynch HT et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22:1055\u20131062","journal-title":"J Clin Oncol"},{"key":"267_CR14","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1200\/JCO.2002.10.101","volume":"20","author":"V.R. Grann","year":"2002","unstructured":"Grann VR, Jacobson JS, Thomason D et al (2002) Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1 and BRCA2 mutations: an updates decision analysis. J Clin Oncol 20:2520\u20132529","journal-title":"J Clin Oncol"},{"key":"267_CR15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","volume":"340","author":"L.C. Hartmann","year":"1999","unstructured":"Hartmann LC, Schaid DJ, Woods JE et al (1999) Efficacy of prophylactic mastectomy in women with family of breast cancer. N Engl J Med 340: 77\u201384","journal-title":"N Engl J Med"},{"key":"267_CR16","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","volume":"346","author":"N.D. Kauff","year":"2002","unstructured":"Kauff ND, Satagopan JM, Robson ME et al (2002) Risk reducing salpingo-oophorectomy in women with BRCA1 or BRCA2 mutation. N Engl J Med 346:1609\u20131615","journal-title":"N Engl J Med"},{"key":"267_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0959-8049(02)00269-1","volume":"38","author":"T.R. Rebbeck","year":"2002","unstructured":"Rebbeck TR (2002) Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. Eur J Cancer 38:15\u201317","journal-title":"Eur J Cancer"},{"key":"267_CR18","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/cncr.22176","volume":"107","author":"J.C. Boughey","year":"2006","unstructured":"Boughey JC, Khakpom N, Meric-Bernstam F et al (2006) Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer 107:1440\u20131447","journal-title":"Cancer"},{"key":"267_CR19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/1097-0142(20010815)92:4<959::AID-CNCR1406>3.0.CO;2-V","volume":"92","author":"C.M. Julian-Reynier","year":"2001","unstructured":"Julian-Reynier CM, Bouchard LJ, Evans DG et al (2001) Women\u2019s attitudes towards preventive strategies for hereditary breast or ovarian carcinoma differ from one country to another: differences among English, French and Canadian women. Cancer 92:959\u2013968","journal-title":"Cancer"},{"key":"267_CR20","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","volume":"93","author":"L.C. Hartmann","year":"2001","unstructured":"Hartmann LC, Sellers TA, Schaid DJ et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93:1633\u20131637","journal-title":"J Natl Cancer Inst"},{"key":"267_CR21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","volume":"345","author":"H. Meijers-Heijboer","year":"2001","unstructured":"Meijers-Heijboer H, van Geel B, van Putten WL (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 and BRCA2. N Engl J Med 345:159\u2013164","journal-title":"N Engl J Med"},{"key":"267_CR22","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","volume":"292","author":"E. Warner","year":"2004","unstructured":"Warner E, Plewes DB, Hill KA et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography and clinical breast examination. JAMA 292:1317\u20131325","journal-title":"JAMA"},{"key":"267_CR23","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66646-9","volume":"365","author":"M.O. Leach","year":"2005","unstructured":"Leach MO, Boggis CR, Dixon AK et al (2005) Screening with magnetic resonance imaging and mammography of a UK population al high familiar risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365:1769\u20131778","journal-title":"Lancet"},{"key":"267_CR24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa031759","volume":"351","author":"M. Kriege","year":"2004","unstructured":"Kriege M, Brekelmans CT, Boetes C et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familiar or genetic predisposition. N Engl J Med 351:427\u2013437","journal-title":"N Engl J Med"},{"key":"267_CR25","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1200\/JCO.2001.19.4.924","volume":"19","author":"C.T. Brekelmans","year":"2001","unstructured":"Brekelmans CT, Seynaeve C, Bartels CM et al (2001) Effectiveness of breast cancer surveillance in BRCA1 and BRCA2 gene mutation carriers and wo men with high familiar risk. J Clin Oncol 19:924\u2013930","journal-title":"J Clin Oncol"},{"key":"267_CR26","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1002\/cncr.20971","volume":"103","author":"C.D. Lehmen","year":"2005","unstructured":"Lehmen CD, Blume JD, Weatherall P et al (2005) Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 103:1898\u20131905","journal-title":"Cancer"},{"key":"267_CR27","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/bmj.306.6884.1025","volume":"306","author":"T.H. Bourne","year":"1993","unstructured":"Bourne TH, Campell S, Reynolds KM et al (1993) Screening for early familiar ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. BMJ 306:1025\u20131029","journal-title":"BMJ"},{"key":"267_CR28","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.2002.20.5.1260","volume":"20","author":"L. Scheuer","year":"2002","unstructured":"Scheuer L, Kauff N, Robson M et al (2002) Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 20:1260\u20131268","journal-title":"J Clin Oncol"},{"key":"267_CR29","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1200\/JCO.2002.10.101","volume":"20","author":"V.R. Grann","year":"2002","unstructured":"Grann VR, Jacobson JS, Thomason D et al (2002) Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1\/2 mutations: an updated decision analysis. J Clin Oncol 20:2520\u20132529","journal-title":"J Clin Oncol"},{"key":"267_CR30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ygyno.2005.05.002","volume":"98","author":"Society of Gynecologic Oncologists Clinical Practice Committee","year":"2005","unstructured":"Society of Gynecologic Oncologists Clinical Practice Committee (2005) Statement on prophylactic salpingo-oophorectomy. Gynecol Oncol 98:179\u2013181","journal-title":"Gynecol Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-008-0267-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-008-0267-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-008-0267-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:50:42Z","timestamp":1559447442000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-008-0267-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["267"],"URL":"https:\/\/doi.org\/10.1007\/s12094-008-0267-9","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}